Special Guest · 8:00–8:15 AM PT
?
Special guest
Q1 | IRVINE, ORANGE COUNTY, CA - Known as a medtech powerhouse, OC leads with nearly 50,000 experts and a dense concentration of life science, researchers and medical device companies. Home to Edwards Lifesciences and Allergan and over $40B in economic output. Speaker is Karin Koch: https://www.linkedin.com/in/karin-koch-241482125/
Pitches · 8:15–9:30 AM PT
MedServ
, CEO · viraj@medservmarketplace.com
Exactice Medical
Michael Wood, CEO · michael.wood@exacticemed.com
Exactice is developing a combined imaging and transseptal (TS) access device intended to make transseptal procedures faster and safer with improved imaging quality.
Round
$500K Post-money SAFE @ $5M
Closed
Nothing closed or committed yet
FDA milestone
No FDA interactions yet
FDA timeline
510(k) anticipated in 12–18 months (2027); no clinical trial anticipated before 510(k) approval
DD package
Yes — available under CDA
Traction: Animal lab testing planned for summer 2026; positive animal lab results vs standard of care with 6 operators; premier imaging partner in progress; strategics requested updates and KOL testing
What they're looking for: Advisors/KOLs in imaging/electrophysiology; advisors in regulatory affairs, quality, and manufacturing
Lucidify
Divya Chander, CEO · Divya@lucidifyai.com
Lucidify builds AI-powered brain monitoring systems that convert wearable EEG into actionable biomarkers.
Round
$2m Post-money SAFE @ $10m
Closed
$350k
FDA milestone
Regulatory roadmap prepared by highly recognized regulatory partner in preparation for 510k submission.
FDA timeline
Q3 2028
Other groups in round
Esther Dyson and other individual angel investors
DD package
Yes
Traction: IRB Approved for Stanford Study and registered on clinicaltrials.gov
What they're looking for: Introductions to Neuro-Inflamation KOLs and Hospital Systems GTM Advisors.